共 50 条
- [1] Time To Add-On Medication Use for Patients with Type 2 Diabetes Mellitus (T2DM) Who Failed Metformin Monotherapy[J]. DIABETES, 2010, 59 : A70 - +Qiu, YingFu, Alex Z.Radican, Larry
- [2] TIME TO ADD-ON MEDICATION USE FOR PATIENTS WITH TYPE 2 DIABETES MELLITUS (T2DM) WHO FAILED METFORMIN MONOTHERAPY[J]. VALUE IN HEALTH, 2010, 13 (07) : A299 - A299Qiu, Y.Fu, A. Z.Radican, L.
- [3] Patient Characteristics Associated with Add-On Medication Treatment for Patients with Type 2 Diabetes Mellitus (T2DM) Who Failed Metformin Monotherapy[J]. DIABETES, 2010, 59 : A604 - A604Qiu, YingFu, Alex Z.Radican, Larry
- [4] Efficacy and Safety of Saxagliptin Add-on to Metformin Compared with Acarbose Add-on to Metformin in Patients with Type 2 Diabetes Mellitus (T2DM) Inadequately Controlled with Metformin Monotherapy[J]. DIABETES, 2016, 65 : A293 - A293Du, JinLiang, LiFang, HuiXu, FengmeiLi, WeiShen, LiyaMu, Yiming
- [5] Empagliflozin as Add-On to Metformin for 24 Weeks Improves Glycemic Control in Patients With Type 2 Diabetes (T2DM)[J]. DIABETES, 2013, 62 : A282 - A282Haering, Hans-UlrichMerker, LudwigSeewaldt-Becker, ElkeWeimer, MarcMeinicke, ThomasBroedl, Uli C.Woerle, Hans J.
- [6] Empagliflozin as Add-On to Pioglitazone With or Without Metformin Improves Glycemic Control in Patients With Type 2 Diabetes (T2DM)[J]. DIABETES, 2013, 62 : A291 - A291Kovacs, ChristopherSeshiah, VeeraswamySwallow, RosJones, RussellRattunde, HenningWoerle, Hans J.Broedl, Uli C.
- [7] Time to add-on medication use for patients with type 2 diabetes who failed metformin mono therapy[J]. DIABETOLOGIA, 2010, 53Qiu, Y.Fu, A. Z.Radican, L.
- [8] Empagliflozin as Add-On to Metformin Plus Sulfonylurea (SU) for 24 Weeks Improves Glycemic Control in Patients With Type 2 Diabetes (T2DM)[J]. DIABETES, 2013, 62 : A279 - A279Haering, Hans-UlrichMerker, LudwigSeewaldt-Becker, ElkeWeimer, MarcMeinicke, ThomasWoerle, Hans J.Broedl, Uli C.
- [9] Empagliflozin (EMPA) for ≥76 Weeks as Add-on to Metformin in Patients with Type 2 Diabetes (T2DM)[J]. DIABETES, 2014, 63 : A278 - A278Merker, LudwigHaering, Hans-UlrichChristiansen, Anita VedelRoux, FlavienSalsali, AfshinKim, GabrielMeinicke, ThomasWoerle, Hans J.Broedl, Uli C.
- [10] Empagliflozin (EMPA) for ≥76 Weeks As Add-on to Metformin in Patients with Type 2 Diabetes (T2DM)[J]. ENDOCRINE REVIEWS, 2014, 35 (03)Merker, LudwigHaering, Hans-UlrichChristiansen, Anita VedelRoux, FlavienSalsali, AfshinKim, GabrielMeinicke, ThomasWoerle, Hans-JuergenBroedl, Uli C.